Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

2-[4-[4-[3,4-bis[2-(diethylamino)ethoxy]phenyl]butyl]-2-[2-(diethylamino)ethoxy]phenoxy]-N,N-diethylethanamine , CAS No.B609511, Inhibitor of baculoviral IAP repeat containing 5

Item Number
B609511
Grouped product items
SKUSizeAvailabilityPrice Qty
B609511-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$700.90
B609511-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

Specifications & PurityMoligand™
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of baculoviral IAP repeat containing 5

Associated Targets(Human)

BIRC5 Tchem Baculoviral IAP repeat-containing protein 5 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences
Baculoviral IAP repeat-containing protein 5 vaccine antigenVACCINE ANTIGENALA5989Baculoviral IAP repeat-containing protein 5SINGLE PROTEINHomo sapiens

PubMed: [1]


Names and Identifiers

IUPAC Name 2-[4-[4-[3,4-bis[2-(diethylamino)ethoxy]phenyl]butyl]-2-[2-(diethylamino)ethoxy]phenoxy]-N,N-diethylethanamine
INCHI InChI=1S/C40H70N4O4/c1-9-41(10-2)25-29-45-37-23-21-35(33-39(37)47-31-27-43(13-5)14-6)19-17-18-20-36-22-24-38(46-30-26-42(11-3)12-4)40(34-36)48-32-28-44(15-7)16-8/h21-24,33-34H,9-20,25-32H2,1-8H3
InChi Key QROCYVPJPWZLIK-UHFFFAOYSA-N
Canonical SMILES CCN(CCOc1cc(CCCCc2ccc(c(c2)OCCN(CC)CC)OCCN(CC)CC)ccc1OCCN(CC)CC)CC
Isomeric SMILES CCN(CC)CCOC1=C(C=C(C=C1)CCCCC2=CC(=C(C=C2)OCCN(CC)CC)OCCN(CC)CC)OCCN(CC)CC
PubChem CID 73349604

Certificates

C of A & Other Certificates(BSE/TSE, COO)

Related Documents

References

1. Ho SS, Go ML.  (2013)  Restraining the flexibility of the central linker in terameprocol results in constrained analogs with improved growth inhibitory activity..  Bioorg Med Chem Lett,  23  (22): (6127-33).  [PMID:24080463] [10.1021/op500134e]

Solution Calculators